Physician

Aarup Anant Kubal, M.D.

According to 2025 Medicare claims, Aarup Kubal, M.D. (NPI: 1780720219) practices ophthalmology in the Fort Lauderdale-Pompano Beach-Sunrise, FL market, with the plurality of this provider's patient population coming from Broward, FL. This provider's primary affiliated billing organization is RETINA MACULA SPECIALISTS OF MIAMI LLC (NPI: 1982946612; TIN: 461758367) and primary practice location at 33180-1266.

Kubal's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 963 traditional Medicare patients, billed 5,205 HCPCS/CPT codes, and received $366,856 in Medicare payments. The top billing code was 92014 (Established patient complete exam of visual system). Part D data shows 8,443 prescription claims across 1,650 beneficiaries totaling $1,164,868 in drug costs, led by Restasis (Cyclosporine). Open Payments data shows 77 records totaling $10,866. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has changed little. Concurrently, Part D prescription costs have moved sharply higher in recent years, from $461,798 to $1,164,868. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$222K$444K2015 Medicare payment: $318,089 (USD; Tot_Mdcr_Pymt_Amt)2016 Medicare payment: $329,736 (USD; Tot_Mdcr_Pymt_Amt)2017 Medicare payment: $303,462 (USD; Tot_Mdcr_Pymt_Amt)2018 Medicare payment: $295,328 (USD; Tot_Mdcr_Pymt_Amt)2019 Medicare payment: $377,954 (USD; Tot_Mdcr_Pymt_Amt)2020 Medicare payment: $380,142 (USD; Tot_Mdcr_Pymt_Amt)2021 Medicare payment: $363,701 (USD; Tot_Mdcr_Pymt_Amt)2022 Medicare payment: $361,125 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $443,811 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $366,856 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
20157997,973$318,089
20167107,386$329,736
20177158,716$303,462
20185999,247$295,328
20197569,723$377,954
20207418,129$380,142
20217629,912$363,701
20228927,893$361,125
20231,0126,142$443,811
20249635,205$366,856

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$726K$1.5M2015 Drug cost: $461,798 (USD; Tot_Drug_Cst)2016 Drug cost: $496,974 (USD; Tot_Drug_Cst)2017 Drug cost: $502,763 (USD; Tot_Drug_Cst)2018 Drug cost: $584,731 (USD; Tot_Drug_Cst)2019 Drug cost: $733,850 (USD; Tot_Drug_Cst)2020 Drug cost: $970,711 (USD; Tot_Drug_Cst)2021 Drug cost: $1,219,351 (USD; Tot_Drug_Cst)2022 Drug cost: $1,452,725 (USD; Tot_Drug_Cst)2023 Drug cost: $1,424,045 (USD; Tot_Drug_Cst)2024 Drug cost: $1,164,868 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
20158154,590$461,798
20169524,950$496,974
20171,0494,514$502,763
20189664,648$584,731
20191,1445,081$733,850
20201,4016,322$970,711
20211,4727,431$1,219,351
20221,5938,206$1,452,725
20231,6178,738$1,424,045
20241,6508,443$1,164,868

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
92014Established patient complete exam of visual system606921$89
765122d ultrasound scan of eye tissue and structures212215$68
92083Exam of visual field with extended testing328351$47
92134Imaging of retina390423$28
92133Imaging of optic nerve290310$25

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
RestasisCyclosporine34813,200$251,470
LumiganBimatoprost22313,895$127,890
CombiganBrimonidine Tartrate/Timolol21813,344$98,150
RhopressaNetarsudil Mesylate2358,264$94,029
RocklatanNetarsudil Mesylat/Latanoprost2237,149$90,566

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.77$10,866ABBVIE INC.
Research PaymentsReported research-related payment or transfer-of-value amount.0$0N/R
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for Aarup Anant Kubal, M.D.?

Tedicare shows public-source Medicare data for Aarup Anant Kubal, M.D. (NPI 1780720219), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Aarup Anant Kubal, M.D. have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Aarup Anant Kubal, M.D.?

Aarup Anant Kubal, M.D. is linked to RETINA MACULA SPECIALISTS OF MIAMI LLC (billing NPI 1982946612) in the available physician profile data.

Does Aarup Anant Kubal, M.D. have Open Payments data?

Aarup Anant Kubal, M.D. has 77 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.